Rezultaty - Amthauer, Holger
- Rezultaty 1 - 20 Rezultaty od 52
- Idź do następnej strony
-
1
-
2
A case report of an excellent response to interferon- α in a patient with functional metastasized neuroendocrine tumor refractory to other treatments od Özdirik, Burcin, Tacke, Frank, Benz, Fabian, Amthauer, Holger, Fehrenbach, Uli, Roderburg, Christoph, Jann, Henning
Wydane 2020Text -
3
Asphericity of tumor FDG uptake in non-small cell lung cancer: reproducibility and implications for harmonization in multicenter studies od Rogasch, Julian M. M., Furth, Christian, Bluemel, Stephanie, Radojewski, Piotr, Amthauer, Holger, Hofheinz, Frank
Wydane 2020Text -
4
Reconstructed spatial resolution and contrast recovery with Bayesian penalized likelihood reconstruction (Q.Clear) for FDG-PET compared to time-of-flight (TOF) with point spread fu... od Rogasch, Julian M., Suleiman, Said, Hofheinz, Frank, Bluemel, Stephanie, Lukas, Mathias, Amthauer, Holger, Furth, Christian
Wydane 2020Text -
5
Impact of the size of the normal database on the performance of the specific binding ratio in dopamine transporter SPECT od Schmitz-Steinkrüger, Helen, Lange, Catharina, Apostolova, Ivayla, Amthauer, Holger, Lehnert, Wencke, Klutmann, Susanne, Buchert, Ralph
Wydane 2020Text -
6
Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin’s lymphoma od Rogasch, Julian M. M., Hundsdoerfer, Patrick, Hofheinz, Frank, Wedel, Florian, Schatka, Imke, Amthauer, Holger, Furth, Christian
Wydane 2018Text -
7
(68)Ga-PSMA-PET/CT for the evaluation of pulmonary metastases and opacities in patients with prostate cancer od Damjanovic, Jonathan, Janssen, Jan-Carlo, Furth, Christian, Diederichs, Gerd, Walter, Thula, Amthauer, Holger, Makowski, Marcus R.
Wydane 2018Text -
8
Prognostic Value of the Largest Lesion Size for Progression-Free Survival in Patients with NET Undergoing Salvage PRRT with [(177)Lu]Lu-DOTATOC od Galler, Markus, Rogasch, Julian M. M., Huang, Kai, Jann, Henning, Plehm, Kristina, Wetz, Christoph, Amthauer, Holger
Wydane 2022Text -
9
Hybrid SPECT/CT for the assessment of a painful hip after uncemented total hip arthroplasty od Dobrindt, Oliver, Amthauer, Holger, Krueger, Alexander, Ruf, Juri, Wissel, Heiko, Grosser, Oliver S, Seidensticker, Max, Lohmann, Christoph H
Wydane 2015Text -
10
Comparative evaluation of SUV, tumor-to-blood standard uptake ratio (SUR), and dual time point measurements for assessment of the metabolic uptake rate in FDG PET od Hofheinz, Frank, Hoff, Jörg van den, Steffen, Ingo G., Lougovski, Alexandr, Ego, Kilian, Amthauer, Holger, Apostolova, Ivayla
Wydane 2016Text -
11
Influence of Gender on Therapy and Outcome of Neuroendocrine Tumors of Gastroenteropancreatic Origin: A Single-Center Analysis od Mogl, Martina T., Dobrindt, Eva M., Buschermöhle, Josephine, Bures, Claudia, Pratschke, Johann, Amthauer, Holger, Wetz, Christoph, Jann, Henning
Wydane 2020Text -
12
Optimization of SPECT/CT imaging protocols for quantitative and qualitative (99m)Tc SPECT od Kupitz, Dennis, Wissel, Heiko, Wuestemann, Jan, Bluemel, Stephanie, Pech, Maciej, Amthauer, Holger, Kreissl, Michael C., Grosser, Oliver S.
Wydane 2021Text -
13
Software-assisted dosimetry in peptide receptor radionuclide therapy with (177)Lutetium-DOTATATE for various imaging scenarios od Kupitz, Dennis, Wetz, Christoph, Wissel, Heiko, Wedel, Florian, Apostolova, Ivayla, Wallbaum, Thekla, Ricke, Jens, Amthauer, Holger, Grosser, Oliver S.
Wydane 2017Text -
14
Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival od Seidensticker, Ricarda, Damm, Robert, Enge, Julia, Seidensticker, Max, Mohnike, Konrad, Pech, Maciej, Hass, Peter, Amthauer, Holger, Ricke, Jens
Wydane 2018Text -
15
Asphericity of Somatostatin Receptor Expression in Neuroendocrine Tumors: An Innovative Predictor of Outcome in Everolimus Treatment? od Wetz, Christoph, Rogasch, Julian, Genseke, Philipp, Schatka, Imke, Furth, Christian, Kreissl, Michael, Jann, Henning, Venerito, Marino, Amthauer, Holger
Wydane 2020Text -
16
The Prognostic Value of the De Ritis Ratio for Progression-Free Survival in Patients with NET Undergoing [(177)Lu]Lu-DOTATOC-PRRT: A Retrospective Analysis od Ruhwedel, Tristan, Rogasch, Julian M. M., Huang, Kai, Jann, Henning, Schatka, Imke, Furth, Christian, Amthauer, Holger, Wetz, Christoph
Wydane 2021Text -
17
Correlation Between Quantitative PSMA PET Parameters and Clinical Risk Factors in Non-Metastatic Primary Prostate Cancer Patients od Zschaeck, Sebastian, Andela, Stephanie Bela, Amthauer, Holger, Furth, Christian, Rogasch, Julian M., Beck, Marcus, Hofheinz, Frank, Huang, Kai
Wydane 2022Text -
18
Positive FP-CIT SPECT (DaTSCAN) in Clinical Alzheimer's Disease – An Unexpected Finding? od Bittner, Verena, Ullrich, Gerhard, Thormann, Markus, Müller, Notger G., Friederichs, Christin, Amthauer, Holger, Heinze, Hans-Jochen, Bittner, Daniel M.
Wydane 2011Text -
19
Explorative analyses on the value of interim PET for prediction of response in pediatric and adolescent non-Hodgkin lymphoma patients od Furth, Christian, Steffen, Ingo G, Erdrich, Anne S, Hundsdoerfer, Patrick, Ruf, Juri, Henze, Günter, Schönberger, Stefan, Amthauer, Holger, Hautzel, Hubertus
Wydane 2013Text -
20
Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future od Stueven, Anna Kathrin, Kayser, Antonin, Wetz, Christoph, Amthauer, Holger, Wree, Alexander, Tacke, Frank, Wiedenmann, Bertram, Roderburg, Christoph, Jann, Henning
Wydane 2019Text